WallStreetZenWallStreetZen

NASDAQ: MDGL
Madrigal Pharmaceuticals Inc Earnings & Revenue

MDGL earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$444.3M
Current Profit Margin
0%

MDGL Return on Equity

Current Company
-128.6%
Current Industry
16.6%
Current Market
28.2%
MDGL's Return on Equity (-128.6%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when MDGL announces earnings.

MDGL Return on Assets

Current Company
-78.5%
Current Industry
3.1%
MDGL is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

MDGL Return on Capital Employed

Current Company
-44.43%
Current Industry
-43.5%
MDGL has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

MDGL vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
MDGL$0.00-$429.49M-$444.28MN/AN/A
APLS$524.07M-$384.48M-$417.27M+102.94%N/A
CYTK$3.75M-$489.78M-$530.60M-35.91%N/A
CRSP$271.71M-$195.23M-$217.14M+164.62%N/A
KRYS$95.95M$65.04M$57.16MN/AN/A

Madrigal Pharmaceuticals Earnings & Revenue FAQ

What were MDGL's earnings last quarter?

On Invalid Date, Madrigal Pharmaceuticals (NASDAQ: MDGL) reported Q1 2024 earnings per share (EPS) of -$7.38, up 74.47% year over year. Total Madrigal Pharmaceuticals earnings for the quarter were -$147.54 million. In the same quarter last year, Madrigal Pharmaceuticals's earnings per share (EPS) was -$4.23.

If you're new to stock investing, here's how to buy Madrigal Pharmaceuticals stock.

What was MDGL's earnings growth in the past year?

As of Q2 2024, Madrigal Pharmaceuticals's earnings has grown year over year. Madrigal Pharmaceuticals's earnings in the past year totalled -$444.28 million.

What was MDGL's revenue last quarter?

On Invalid Date, Madrigal Pharmaceuticals (NASDAQ: MDGL) reported Q1 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Madrigal Pharmaceuticals's revenue was $0.00.

What was MDGL's revenue growth in the past year?

As of Q2 2024, Madrigal Pharmaceuticals's revenue has grown null year over year. Madrigal Pharmaceuticals's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.